These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 35253251)

  • 21. Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis.
    Abulfathi AA; Decloedt EH; Svensson EM; Diacon AH; Donald P; Reuter H
    Clin Pharmacokinet; 2019 Sep; 58(9):1103-1129. PubMed ID: 31049868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging data on rifampicin pharmacokinetics and approaches to optimal dosing in children with tuberculosis.
    Radtke KK; Svensson EM; van der Laan LE; Hesseling AC; Savic RM; Garcia-Prats AJ
    Expert Rev Clin Pharmacol; 2022 Feb; 15(2):161-174. PubMed ID: 35285351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
    Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Theophylline: a review of population pharmacokinetic analyses.
    Ma YJ; Jiang DQ; Meng JX; Li MX; Zhao HH; Wang Y; Wang LQ
    J Clin Pharm Ther; 2016 Dec; 41(6):594-601. PubMed ID: 27578172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review.
    Pariente G; Leibson T; Carls A; Adams-Webber T; Ito S; Koren G
    PLoS Med; 2016 Nov; 13(11):e1002160. PubMed ID: 27802281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population pharmacokinetics of doxorubicin: A systematic review.
    Methaneethorn J; Tengcharoen K; Leelakanok N; AlEjielat R
    Asia Pac J Clin Oncol; 2023 Feb; 19(1):9-26. PubMed ID: 35415961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.
    Verbeeck RK; Günther G; Kibuule D; Hunter C; Rennie TW
    Eur J Clin Pharmacol; 2016 Aug; 72(8):905-16. PubMed ID: 27305904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The challenges of pharmacokinetic variability of first-line anti-TB drugs.
    Devaleenal Daniel B; Ramachandran G; Swaminathan S
    Expert Rev Clin Pharmacol; 2017 Jan; 10(1):47-58. PubMed ID: 27724114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population Pharmacokinetic Analyses of Lithium: A Systematic Review.
    Methaneethorn J
    Eur J Drug Metab Pharmacokinet; 2018 Feb; 43(1):25-34. PubMed ID: 28555320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
    Steingart KR; Sohn H; Schiller I; Kloda LA; Boehme CC; Pai M; Dendukuri N
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009593. PubMed ID: 23440842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of population pharmacokinetic models of gentamicin in paediatric patients.
    Crcek M; Zdovc J; Kerec Kos M
    J Clin Pharm Ther; 2019 Oct; 44(5):659-674. PubMed ID: 31102287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amikacin in Critically Ill Patients: A Review of Population Pharmacokinetic Studies.
    Marsot A; Guilhaumou R; Riff C; Blin O
    Clin Pharmacokinet; 2017 Feb; 56(2):127-138. PubMed ID: 27324191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population pharmacokinetics of polymyxin B: a systematic review.
    Chen N; Guo J; Xie J; Xu M; Hao X; Ma K; Rao Y
    Ann Transl Med; 2022 Feb; 10(4):231. PubMed ID: 35280373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invasiveness of pharmacokinetic studies in children: a systematic review.
    Altamimi MI; Choonara I; Sammons H
    BMJ Open; 2016 Jul; 6(7):e010484. PubMed ID: 27431899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population pharmacokinetics analyses of rifampicin in adult and children populations: A systematic review.
    Muda MR; Harun SN; Syed Sulaiman SA; Sheikh Ghadzi SM
    Br J Clin Pharmacol; 2022 Jul; 88(7):3132-3152. PubMed ID: 35253251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sources of lamotrigine pharmacokinetic variability: A systematic review of population pharmacokinetic analyses.
    Methaneethorn J; Leelakanok N
    Seizure; 2020 Nov; 82():133-147. PubMed ID: 33060011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vancomycin: a review of population pharmacokinetic analyses.
    Marsot A; Boulamery A; Bruguerolle B; Simon N
    Clin Pharmacokinet; 2012 Jan; 51(1):1-13. PubMed ID: 22149255
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.